The Reagan-Udall Foundation for the FDA hosted a public meeting titled “Advancing Treatments for Post-Traumatic Stress Disorder,” in alignment with FDA’s ongoing efforts to better understand the medical needs surrounding PTSD with a goal of facilitating treatment development. This report summarizes the event that included a panel discussion with federal partners exploring efforts to accelerate treatment development for PTSD, including the potential role for psychedelic drugs.
- About
- Projects
- Column 1
- Advancing Regulatory Science
- Animal Health & Veterinary Medicine
- Expanded Access
- FDA Patient Listening Sessions
- Column 2
- Food & Nutrition
- Improving Access to FDA Information
- Research
- Substance Use Disorders
- Column 1
- News and Events
- Expanded Access eRequest